Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial®) vs hylan G-F20 (Synvisc®) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study

Osteoarthritis and Cartilage

Volumn 19, Issue 11, 2011, Pages 1294-1300

  Pavelka, K ^a   Uebelhart, D ^b,c  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Valmont Private Rehabilitation Clinic   (Switzerland)

Author keywords

Hyaluronic acid; Hylan; Knee osteoarthritis

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYLAN G F20; SINOVIAL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEMATOMA; HUMAN; INJECTION PAIN; INJECTION SITE BLEEDING; INJECTION SITE PAIN; JOINT SWELLING; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME; VISCOSUPPLEMENTS;

EID: 80053647615     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.07.016     Document Type: Article

References (23)

1. Barron M.C., Rubin B.R. Managing osteoarthritic knee pain. J Am Osteopath Assoc 2007 Nov, 107(10 Suppl 6):ES21-ES27.
2. Wang C.T., Lin J., Chang C.J., Lin Y.T., Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg 2004 Mar, 86-A(3):538-545.
3. Bjordal J.M., Ljunggren A.E., Klovning A., Slordal L. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 2004 Dec 4, 329(7478):1317.
4. Balazs E.A., Watson D., Duff I.F., Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 1967 Aug, 10(4):357-376.
5. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, (2):CD005321.
6. Lo G.H., LaValley M., McAlindon T., Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003 Dec 17, 290(23):3115-3121.
7. Bellamy N. Hyaluronic acid and knee osteoarthritis. J Fam Pract 2006 Nov, 55(11):967-968.
8. Laurent T.C., Fraser J.R. Hyaluronan. Faseb J 1992 Apr, 6(7):2397-2404.
9. Altman R.D. Status of hyaluronan supplementation therapy in osteoarthritis. Curr Rheumatol Rep 2003 Feb, 5(1):7-14.
10. American College of Rheumatology Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000 Sep, 43(9):1905-1915.
11. Pendleton A., Arden N., Dougados M., Doherty M., Bannwarth B., Bijlsma J.W., et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000 Dec, 59(12):936-944.
12. Genzyme. Synvisc® Package Insert.
13. Theiler R., Bruhlmann P. Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Curr Med Res Opin 2005 Nov, 21(11):1727-1733.
14. Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L.W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988 Dec, 15(12):1833-1840.
15. Lequesne M., Samson M., Gerard P., Mery C. [Pain-function indices for the follow-up of osteoarthritis of the hip and the knee]. Rev Rhum Mal Osteoartic 1990 Oct 30, 57(9(Pt 2)):32S-36S.
16. Strand V., Kelman A. Outcome measures in osteoarthritis: randomized controlled trials. Curr Rheumatol Rep 2004 Feb, 6(1):20-30.
17. Pham T., van der Heijde D., Altman R.D., Anderson J.J., Bellamy N., Hochberg M., et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004 May, 12(5):389-399.
18. Ehrich E.W., Davies G.M., Watson D.J., Bolognese J.A., Seidenberg B.C., Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000 Nov, 27(11):2635-2641.
19. Angst F., Aeschlimann A., Michel B.A., Stucki G. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol 2002 Jan, 29(1):131-138.
20. Bijlsma J.W. Patient centred outcomes in osteoarthritis. Ann Rheum Dis 2005 Jan, 64(1):1-2.
21. Tubach F., Ravaud P., Baron G., Falissard B., Logeart I., Bellamy N., et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005 Jan, 64(1):29-33.
22. Kirchner M., Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 2006 Feb, 14(2):154-162.
23. Reichenbach S., Blank S., Rutjes A.W.S., Shang A., King E.A., Dieppe P.A., et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 2007 Dec 15, 57(8):1410-1418.